Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 5/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 5/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 5/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | CHRNB3 | Q05901 | 2/20 | 0.35 |
| ▸ | CHRNA6 | Q15825 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | PLG | P00747 | 1/20 | 0.32 |
| ▸ | PLAT | P00750 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.31 |
| ▸ | GABRP | O00591 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4279 | 1.00 | — | — | |
| SCHEMBL1060400 | 1.00 | CHRNB2 (0.36) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL890380 | 1.00 | CHRNB2 (0.36) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| Hydrochloric Acid SCHEMBL1880027 | 0.96 | — | — | |
| Bicarbonate SCHEMBL27911841 | 0.93 | LMNA (0.35) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL1087909 | 0.93 | CHRNB2 (0.33) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL21391917 | 0.90 | CES2 (0.43) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL2153805 | 0.90 | CHRNB2 (0.37) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| SCHEMBL13044828 | 0.90 | CHRNB2 (0.37) | CHRNB2CHRNA3CHRNA4CHRNB4CHRNA7 | |
| Methylene Chloride SCHEMBL28166563 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179243-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | TOSOH CORPORATION (JP) | 2025-06-05 | — | — | US | disclosed |
| EP-4455128-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | Tosoh Corporation (JP) | 2024-10-30 | — | — | EP | disclosed |
| WO-2023120638-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | 東ソー株式会社 | 2023-06-29 | — | — | WO | disclosed |
| CN-112512589-A | Dimeric immunomodulatory compounds against CEREBLON-based mechanisms | H·李·莫菲特癌症中心研究有限公司 | 2021-03-16 | — | — | CN | disclosed |
| EP-3214064-B1 | METHOD FOR PREPARING 1,4-CYCLOHEXANEDICARBOXYLIC ACID DICHLORIDE | TORAY FINECHEMICALS CO LTD (JP) | 2019-10-09 | — | — | EP | disclosed |
| US-20190016662-A1 | METHOD OF PRODUCING ACID HALIDE SOLUTION AND METHOD OF PRODUCING MONOESTER COMPOUND | ZEON CORPORATION (JP) | 2019-01-17 | — | — | US | disclosed |
| EP-3214064-A1 | METHOD FOR PREPARING 1,4-CYCLOHEXANEDICARBOXYLIC ACID DICHLORIDE | Toray Fine Chemicals Co., Ltd. (JP) | 2017-09-06 | — | — | EP | disclosed |
| US-20150133663-A1 | NOVEL SYNTHESIS METHOD | GE HEALTHCARE LIMITED (GB) | 2015-05-14 | — | — | US | disclosed |
| US-20150083657-A1 | MEMBRANE AND METHOD FOR MAKING THE SAME | GENERAL ELETRIC COMPANY (US) | 2015-03-26 | — | — | US | disclosed |
| US-20140140928-A1 | 5HT1A ANTAGONIST USEFUL FOR IN VIVO IMAGING | GE HEALTHCARE LIMITED (GB) | 2014-05-22 | — | — | US | disclosed |
| US-8616380-B2 | Reverse osmosis composite membranes for boron removal | GENERAL ELECTRIC COMPANY (US) | 2013-12-31 | — | — | US | disclosed |
| US-8580341-B2 | Method of making composite membrane | GENERAL ELECTRIC COMPANY (US) | 2013-11-12 | — | — | US | disclosed |
| US-20120292249-A1 | COMPOSITE MEMBRANE AND METHOD OF MAKING | GENERAL ELECTRIC COMPANY (US) | 2012-11-22 | — | — | US | disclosed |
| US-20120255909-A1 | REVERSE OSMOSIS COMPOSITE MEMBRANES FOR BORON REMOVAL | GENERAL ELECTRIC COMPANY (US) | 2012-10-11 | — | — | US | disclosed |
| EP-2473261-A2 | REVERSE OSMOSIS COMPOSITE MEMBRANES FOR BORON REMOVAL | General Electric Company (US) | 2012-07-11 | — | — | EP | disclosed |
| US-20110049055-A1 | REVERSE OSMOSIS COMPOSITE MEMBRANES FOR BORON REMOVAL | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | US | disclosed |
| WO-2011025607-A2 | REVERSE OSMOSIS COMPOSITE MEMBRANES FOR BORON REMOVAL | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | WO | disclosed |
| WO-2010135033-A1 | COMPOSITE MEMBRANE AND METHOD OF MAKING | GENERAL ELECTRIC COMPANY (US) | 2010-11-25 | — | — | WO | disclosed |
| US-20100297429-A1 | COMPOSITE MEMBRANE AND METHOD OF MAKING | GENERAL ELECTRIC COMPANY (US) | 2010-11-25 | — | — | US | disclosed |
| US-4734486-A | Polyamide comprising fluorinated xylyene moieties | ICI AMERICAS INC. (US) | 1988-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179243-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | C9, RNF4, F12 | CHRNB2 2698/4885CHRNA3 1471/4885CHRNA4 1693/4885 |
| US-20150133663-A1 | NOVEL SYNTHESIS METHOD | HTR1A, HTR5A, TPH1 | CHRNB2 138/4885CHRNA3 115/4885CHRNA4 110/4885 |
| US-20190016662-A1 | METHOD OF PRODUCING ACID HALIDE SOLUTION AND METHOD OF PRODUCING MONOESTER COMPOUND | HACL2, LIPA, HDHD5 | CHRNB2 4790/4885CHRNA3 4625/4885CHRNA4 4632/4885 |
| US-20140140928-A1 | 5HT1A ANTAGONIST USEFUL FOR IN VIVO IMAGING | HTR1A, HTR1E, HTR5A | CHRNB2 243/4885CHRNA3 200/4885CHRNA4 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.